PH15491A - Pyrrolidine derivatives - Google Patents

Pyrrolidine derivatives

Info

Publication number
PH15491A
PH15491A PH22107A PH22107A PH15491A PH 15491 A PH15491 A PH 15491A PH 22107 A PH22107 A PH 22107A PH 22107 A PH22107 A PH 22107A PH 15491 A PH15491 A PH 15491A
Authority
PH
Philippines
Prior art keywords
pyrrolidine derivatives
pyrrolidine
derivatives
Prior art date
Application number
PH22107A
Other languages
English (en)
Inventor
Emilio Dr Kyburz
Werner Aschwanden
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH15491A publication Critical patent/PH15491A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PH22107A 1978-02-10 1979-01-25 Pyrrolidine derivatives PH15491A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140378 1978-02-10
CH1198178 1978-11-22

Publications (1)

Publication Number Publication Date
PH15491A true PH15491A (en) 1983-01-31

Family

ID=25687541

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22107A PH15491A (en) 1978-02-10 1979-01-25 Pyrrolidine derivatives

Country Status (34)

Country Link
US (1) US4369139A (fr)
EP (2) EP0005143B1 (fr)
JP (1) JPS6059907B2 (fr)
AR (1) AR220739A1 (fr)
AT (1) AT374787B (fr)
AU (1) AU525514B2 (fr)
BG (1) BG29281A3 (fr)
BR (1) BR7900684A (fr)
CA (1) CA1100515A (fr)
CS (1) CS226182B2 (fr)
CU (1) CU21107A3 (fr)
DD (1) DD141828A5 (fr)
DE (1) DE2963321D1 (fr)
DK (1) DK155278C (fr)
EG (1) EG13873A (fr)
ES (2) ES477587A1 (fr)
FI (1) FI69063C (fr)
GR (1) GR71464B (fr)
HK (1) HK6185A (fr)
HU (1) HU177644B (fr)
IE (1) IE47831B1 (fr)
IL (1) IL56587A0 (fr)
IN (1) IN150106B (fr)
MC (1) MC1257A1 (fr)
MY (1) MY8500340A (fr)
NO (1) NO152046C (fr)
NZ (1) NZ189571A (fr)
OA (1) OA06180A (fr)
PH (1) PH15491A (fr)
PL (1) PL115958B1 (fr)
PT (1) PT69206A (fr)
RO (1) RO76615A (fr)
SU (1) SU931104A3 (fr)
YU (1) YU41330B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131959B (it) * 1979-08-09 1986-06-25 Hoffmann La Roche Derivati pirrolidinici
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4398938A (en) * 1982-05-20 1983-08-16 Velsicol Chemical Corporation N-Acylated lactams and their herbicidal compositions and method of use
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
CH661174GA3 (fr) * 1985-07-10 1987-07-15
US4691853A (en) * 1985-12-30 1987-09-08 Technalytics, Inc. Surgical stapler
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
CA1305148C (fr) * 1987-08-19 1992-07-14 Hiromu Matsumura Derives de carbamoylpyrrolidone et produits pharmaceutiques pour la demence senile
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
JP2585086B2 (ja) * 1988-12-28 1997-02-26 大鵬薬品工業株式会社 ジアザビシクロアルカン誘導体
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JP2803882B2 (ja) * 1990-02-20 1998-09-24 日清製粉株式会社 １―フエノキシカルボニル―２―ピロリジノン誘導体
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
DE69331761T2 (de) * 1992-07-24 2002-09-12 The Regents Of The University Of California, Oakland Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
US5955505A (en) * 1995-02-21 1999-09-21 Nippon Suisan Kaisha, Ltd. Glutamic acid receptor agonist
FR2792833B1 (fr) * 1999-04-27 2002-09-06 Hoffmann La Roche Utilisation de l'acide n-anisoyl-gamma-aminobutyrique ou de l'acide p-anisique pour la preparation d'une composition pharmaceutique
KR100823668B1 (ko) 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
US8858594B2 (en) * 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
EP2604592B1 (fr) 2011-12-12 2014-10-08 Zaklady Farmaceutyczne Polpharma SA Procédé de purification d'aniracetam par cristallisation de solutions aqueuses
CN109651222A (zh) * 2018-12-21 2019-04-19 上海昊航化工有限公司 一种阿尼西坦的催化合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697563A (en) * 1970-06-29 1972-10-10 Inst Chemioterapico Italiano S (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.

Also Published As

Publication number Publication date
NO152046B (no) 1985-04-15
BR7900684A (pt) 1979-09-04
ATA99579A (de) 1983-10-15
PL213340A1 (fr) 1980-03-24
MC1257A1 (fr) 1980-01-14
NZ189571A (en) 1984-07-06
RO76615A (fr) 1981-04-30
OA06180A (fr) 1981-06-30
FI790226A (fi) 1979-08-11
EP0044088A2 (fr) 1982-01-20
IE47831B1 (en) 1984-06-27
AT374787B (de) 1984-05-25
CA1100515A (fr) 1981-05-05
DK155278B (da) 1989-03-20
YU41330B (en) 1987-02-28
SU931104A3 (ru) 1982-05-23
JPS6059907B2 (ja) 1985-12-27
AU4391679A (en) 1979-08-16
AU525514B2 (en) 1982-11-11
EP0005143B1 (fr) 1982-07-14
NO152046C (no) 1985-07-24
MY8500340A (en) 1985-12-31
IL56587A0 (en) 1979-05-31
DE2963321D1 (en) 1982-09-02
JPS54117468A (en) 1979-09-12
EP0044088B1 (fr) 1984-02-22
NO790434L (no) 1979-08-13
EG13873A (en) 1982-12-31
US4369139A (en) 1983-01-18
GR71464B (fr) 1983-05-30
EP0044088A3 (en) 1982-02-03
DK56379A (da) 1979-08-11
ES483756A1 (es) 1980-04-16
IE790246L (en) 1979-08-20
IN150106B (fr) 1982-07-24
DK155278C (da) 1989-07-24
ES477587A1 (es) 1980-01-16
AR220739A1 (es) 1980-11-28
BG29281A3 (en) 1980-10-15
YU28379A (en) 1983-02-28
PT69206A (en) 1979-03-01
DD141828A5 (de) 1980-05-21
HU177644B (en) 1981-11-28
FI69063B (fi) 1985-08-30
CU21107A3 (es) 1988-02-01
CS226182B2 (en) 1984-03-19
HK6185A (en) 1985-02-01
FI69063C (fi) 1985-12-10
PL115958B1 (en) 1981-05-30
EP0005143A1 (fr) 1979-11-14

Similar Documents

Publication Publication Date Title
GB2033893B (en) Tetrazolylalkoxycarbostyril derivatives
PH15491A (en) Pyrrolidine derivatives
GB2012759B (en) Thienohydantoin derivatives
GB2022079B (en) L-leucyl-4-hydroxyanilide derivatives
ZA79452B (en) Pyrrolidine derivatives
GB2038326B (en) Acylaniline derivatives
GB2018757B (en) 3-phenyltetrahydropyridine derivatives
GB2055835B (en) Pyrrolidine derivatives
GB2036744B (en) Eburnane derivatives
GB2017708B (en) Steroid-spirooxazolidinone derivatives
GB2019843B (en) N-alkenylmoranoline derivatives
GB2017691B (en) 2-hydroxymethyl-pyrazine derivatives
GB2052477B (en) Carbamoyl-piperazine derivatives
GB2024806B (en) Onomycin derivatives
GB2013187B (en) Phenylpyrol derivatives
GB2023574B (en) N-cyano-azomethine derivatives
GB2037764B (en) 7-methoxycepgalosporin derivatives
GB2029828B (en) Vincadifformine derivatives
GB2013654B (en) Benziosothiazole derivatives
GB2044251B (en) Phenoxypropanolamine derivatives
MTP839B (en) Pyrrolidine derivative
GB2031879B (en) Amidinopenem derivatives
ZA804702B (en) Pyrrolidine derivatives
GB2111477B (en) Eburnane derivatives
GB2025931B (en) Methane-sulphonamide derivatives

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 11